210 related articles for article (PubMed ID: 30025258)
1. Modulating the masters: chemical tools to dissect CBP and p300 function.
Breen ME; Mapp AK
Curr Opin Chem Biol; 2018 Aug; 45():195-203. PubMed ID: 30025258
[TBL] [Abstract][Full Text] [Related]
2. Role of Intrinsic Protein Disorder in the Function and Interactions of the Transcriptional Coactivators CREB-binding Protein (CBP) and p300.
Dyson HJ; Wright PE
J Biol Chem; 2016 Mar; 291(13):6714-22. PubMed ID: 26851278
[TBL] [Abstract][Full Text] [Related]
3. Challenges in the Structural-Functional Characterization of Multidomain, Partially Disordered Proteins CBP and p300: Preparing Native Proteins and Developing Nanobody Tools.
Bekesi A; Abdellaoui S; Holroyd N; Van Delm W; Pardon E; Pauwels J; Gevaert K; Steyaert J; Derveaux S; Borysik A; Tompa P
Methods Enzymol; 2018; 611():607-675. PubMed ID: 30471702
[TBL] [Abstract][Full Text] [Related]
4. Mapping the interactions of adenoviral E1A proteins with the p160 nuclear receptor coactivator binding domain of CBP.
Haberz P; Arai M; Martinez-Yamout MA; Dyson HJ; Wright PE
Protein Sci; 2016 Dec; 25(12):2256-2267. PubMed ID: 27699893
[TBL] [Abstract][Full Text] [Related]
5. Genomic occupancy of the transcriptional co-activators p300 and CBP.
Holmqvist PH; Mannervik M
Transcription; 2013; 4(1):18-23. PubMed ID: 23131664
[TBL] [Abstract][Full Text] [Related]
6. Differential role for CBP and p300 CREB-binding domain in motor skill learning.
Oliveira AM; Abel T; Brindle PK; Wood MA
Behav Neurosci; 2006 Jun; 120(3):724-9. PubMed ID: 16768624
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide assessment of differential roles for p300 and CBP in transcription regulation.
Ramos YF; Hestand MS; Verlaan M; Krabbendam E; Ariyurek Y; van Galen M; van Dam H; van Ommen GJ; den Dunnen JT; Zantema A; 't Hoen PA
Nucleic Acids Res; 2010 Sep; 38(16):5396-408. PubMed ID: 20435671
[TBL] [Abstract][Full Text] [Related]
8. Double null cells reveal that CBP and p300 are dispensable for p53 targets p21 and Mdm2 but variably required for target genes of other signaling pathways.
Kasper LH; Thomas MC; Zambetti GP; Brindle PK
Cell Cycle; 2011 Jan; 10(2):212-21. PubMed ID: 21220944
[TBL] [Abstract][Full Text] [Related]
9. Targeted degradation of the enhancer lysine acetyltransferases CBP and p300.
Vannam R; Sayilgan J; Ojeda S; Karakyriakou B; Hu E; Kreuzer J; Morris R; Herrera Lopez XI; Rai S; Haas W; Lawrence M; Ott CJ
Cell Chem Biol; 2021 Apr; 28(4):503-514.e12. PubMed ID: 33400925
[TBL] [Abstract][Full Text] [Related]
10. Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomains.
Hay DA; Fedorov O; Martin S; Singleton DC; Tallant C; Wells C; Picaud S; Philpott M; Monteiro OP; Rogers CM; Conway SJ; Rooney TP; Tumber A; Yapp C; Filippakopoulos P; Bunnage ME; Müller S; Knapp S; Schofield CJ; Brennan PE
J Am Chem Soc; 2014 Jul; 136(26):9308-19. PubMed ID: 24946055
[TBL] [Abstract][Full Text] [Related]
11. A Dual-Site Inhibitor of CBP/p300 KIX is a Selective and Effective Modulator of Myb.
Joy ST; Henley MJ; De Salle SN; Beyersdorf MS; Vock IW; Huldin AJL; Mapp AK
J Am Chem Soc; 2021 Sep; 143(37):15056-15062. PubMed ID: 34491719
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for recruitment of CBP/p300 coactivators by STAT1 and STAT2 transactivation domains.
Wojciak JM; Martinez-Yamout MA; Dyson HJ; Wright PE
EMBO J; 2009 Apr; 28(7):948-58. PubMed ID: 19214187
[TBL] [Abstract][Full Text] [Related]
13. Endocrine disrupting chemicals may deregulate DNA repair through estrogen receptor mediated seizing of CBP/p300 acetylase.
Lakshmanan MD; Shaheer K
J Endocrinol Invest; 2020 Sep; 43(9):1189-1196. PubMed ID: 32253726
[TBL] [Abstract][Full Text] [Related]
14. The p300 and CBP Transcriptional Coactivators Are Required for β-Cell and α-Cell Proliferation.
Wong CK; Wade-Vallance AK; Luciani DS; Brindle PK; Lynn FC; Gibson WT
Diabetes; 2018 Mar; 67(3):412-422. PubMed ID: 29217654
[TBL] [Abstract][Full Text] [Related]
15. Expression patterns of histone acetyltransferases p300 and CBP during murine tooth development.
Chen Z; Gao B; Zhou X
In Vitro Cell Dev Biol Anim; 2012 Jan; 48(1):61-8. PubMed ID: 22179676
[TBL] [Abstract][Full Text] [Related]
16. Linking functions: an additional role for an intrinsically disordered linker domain in the transcriptional coactivator CBP.
Contreras-Martos S; Piai A; Kosol S; Varadi M; Bekesi A; Lebrun P; Volkov AN; Gevaert K; Pierattelli R; Felli IC; Tompa P
Sci Rep; 2017 Jul; 7(1):4676. PubMed ID: 28680062
[TBL] [Abstract][Full Text] [Related]
17. MLL3/MLL4 are required for CBP/p300 binding on enhancers and super-enhancer formation in brown adipogenesis.
Lai B; Lee JE; Jang Y; Wang L; Peng W; Ge K
Nucleic Acids Res; 2017 Jun; 45(11):6388-6403. PubMed ID: 28398509
[TBL] [Abstract][Full Text] [Related]
18. CBP/p300 are bimodal regulators of Wnt signaling.
Li J; Sutter C; Parker DS; Blauwkamp T; Fang M; Cadigan KM
EMBO J; 2007 May; 26(9):2284-94. PubMed ID: 17410209
[TBL] [Abstract][Full Text] [Related]
19. Discovery of spirohydantoins as selective, orally bioavailable inhibitors of p300/CBP histone acetyltransferases.
Ji Z; Clark RF; Bhat V; Matthew Hansen T; Lasko LM; Bromberg KD; Manaves V; Algire M; Martin R; Qiu W; Torrent M; Jakob CG; Liu H; Cole PA; Marmorstein R; Kesicki EA; Lai A; Michaelides MR
Bioorg Med Chem Lett; 2021 May; 39():127854. PubMed ID: 33631370
[TBL] [Abstract][Full Text] [Related]
20. Fragment screening and druggability assessment for the CBP/p300 KIX domain through protein-observed 19F NMR spectroscopy.
Gee CT; Koleski EJ; Pomerantz WC
Angew Chem Int Ed Engl; 2015 Mar; 54(12):3735-9. PubMed ID: 25651535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
